Helping brilliant minds discover healthcare solutions

carter-rosetrees

Rosetrees is a private UK charity

Supporting cutting edge medical research for more than 30 years.

The aim is to improve the health and wellbeing of society.

400 projects are supported, from seedcorn 'out of the box' research ideas to large awards, many with co-funders.

The focus is on testing new ideas across the spectrum of medical research to bring the earliest patient benefit.

microscope-icon

Our Philosophy

We use a venture philanthropy approach to promote new ideas. We fund initial seedcorn grants to generate preliminary data that can result in further funding. We also fund larger projects and interdisciplinary grants.

Artboard 1 copy 8

Our Research

Our over-arching goal is to fund research in all areas of medicine that will benefit human health and well-being within 5-10 years.

genes-icon

Rosetrees Team

Rosetrees is run by a small, highly skilled and dedicated team.

DNA-icon

Scientific Advisory Panel

We are advised by a panel of world-leading, internationally renowned scientists.

grant-icon

Grant Schemes

We have a number of different grant schemes available, from small seedcorn awards to major project grants.

Keep up to date with  Rosetrees latest news

 

A study led by Dr Sara Collorone at UCL (funded by Rosetrees + the MS Society) showed that advanced MRI techniques can detect very early changes in brains of MS sufferers. This may lead to more accurate predictions of disease progression. @SaraCollorone https://doi.org/10.1093/brain/awab043

A study led by Dr Sara Collorone at UCL (funded by Rosetrees + the MS Society) showed that advanced MRI techniques can detect very early changes in brains of MS sufferers. This may lead to more accurate predictions of disease progression. @SaraCollorone https://doi.org/10.1093/brain/awab043

A study part-funded by Rosetrees showed that a single dose of the Pfizer/BioNTech vaccine in the context of prior infection with a heterologous variant substantially enhances neutralizing antibody responses against variants. https://science.sciencemag.org/content/early/2021/04/29/science.abh1282 @AineMcKnight @QMUL

A study part-funded by Rosetrees showed that a single dose of the Pfizer/BioNTech vaccine in the context of prior infection with a heterologous variant substantially enhances neutralizing antibody responses against variants. https://science.sciencemag.org/content/early/2021/04/29/science.abh1282 @AineMcKnight @QMUL

Prior #SARSCoV2 infection rescues B and T cell responses to variants after first #COVID19 #vaccine dose, finds research in @ScienceMagazine by @ainemcknight @QMUL @blizard_inst @imperialcollege @uclnews @UKRI_News @RosetreesT @Barts_Charity https://www.qmul.ac.uk/media/news/2021/smd/prior-sars-cov-2-infection-rescues-b-and-t-cell-responses-to-variants-after-first-vaccine-dose.html

Load More...

Lab-grown ‘mini-bile ducts’ used to repair human livers

  Bile Duct Organoid. Credit:Teresa Brevini Rosetrees -funded research, published ...
Read More

Consuming omega-3 fatty acids could prevent asthma

New research has recently been published in the European Respiratory ...
Read More